Figure 3: The effect of tumstatin on alkali induced corneal neovascularization. (A) Inhibition of corneal neovascularization in tumstatintreated group than compared to corneal untreated neovascularization group. Normal cornea (left panel); PBS treated at two weeks after alkaline burn (middle panel); Tumstatin (2 mg/kg body weight) treated at two weeks after alkaline burn (right panel). (B) The score for corneal neovascularization between untreated corneal neovascularization group and tumstatin treated group two weeks after the alkaline burn. The score of the tumstatin-treated group was drastically inhibited compared to that of the untreated corneal neovascularization group (*P<0.02).